Robotic surgery for stomach, pancreas, liver, bile duct, and esophagus conditions
Part of Cancer, Digestive system clinical trials.
This study is testing a new robotic system for several types of abdominal surgeries. Depending on your diagnosis, you may qualify for a specific part of this trial that looks at how well this robot can help with your operation.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- Your body mass index (BMI) must be 26 or lower.
- You must be healthy enough for surgery (ASA score of 3 or less).
- You cannot have had previous abdominal surgery.
- You must have a benign (non-cancer) condition or an early-stage cancer for some procedures.
- You cannot be pregnant or nursing.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new robotic surgical system (da Vinci SP) to remove the gallbladder and, if needed, clear stones from the main bile duct. It is for people with symptomatic gallstones or chronic gallbladder inflammation who cannot have stones removed by endoscopy.
This trial uses a robotic system to assist surgeons during chest and belly surgeries. It aims to see if the robot is safe and effective for procedures like hernia repair, gallbladder removal, or hysterectomy.
This trial tests a faster, robotic-assisted surgery for children ages 6 to 21. It aims to see if completing part of the operation using a robot can be as safe and effective as traditional open surgery, possibly leading to quicker recovery and less pain.
This trial tests a new robotic surgery system for common operations on the colon, rectum, prostate, kidney, bladder, stomach, esophagus, gallbladder, and hiatal hernia. It may offer a less invasive option for patients who need surgery for these conditions.
This study is collecting information from people who have robotic pancreatic surgery to learn more about the procedure and outcomes. It does not test a new treatment but helps doctors improve care.
This trial is testing a newer, less invasive robotic surgery technique that uses just one small incision to remove stomach cancer. It may offer faster recovery and less pain compared to traditional surgery.
Hear when a new Hepatopancreaticobiliary and Foregut Operations trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.